[{"title": "Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxQWmRsckdZSGZ4ak9zY0dmblhONDA2UWlwaEZBejZCQTR2aWN5dWZPVXp5MEkyRS1vNWk3UXFOb2RLdHRIeHEyZWRNTXhBcndZOXR4SmNnU3pOY3Azc3lvcUFMOXAyMDVRSFFGbnlyN3h5dGc3WG9Jak56VTNyV3RWU0VyZnE5Zw?oc=5\" target=\"_blank\">Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 12:26:00 GMT"}, {"title": "It's Time To Be All-In On Novo Nordisk (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPNE5ObU9TeE5XOWF6OWM5LWNzaElEQ2hqOC05b29wb2lWX1B1dG1wS2dLMERGRG1oTUdZMmxybDQxY1MtcXREeFhGN0lib3IzaWhSQW80MVpyeE03M1FVYWpVZlVKalBvaDlTcXdlQlhabDI1eEhIa3FaVFlFWDhFT1J1ZVY?oc=5\" target=\"_blank\">It's Time To Be All-In On Novo Nordisk (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Thu, 14 Aug 2025 14:50:58 GMT"}, {"title": "Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOdl9Tbl9CbFNlcU1tVC1xaWJhcWdwS2gzd0VnckR4dl80d0hReG1zRHVnNUFpa1ltWXMyY3VxTVdpOGdnajd5VDdyQ3NuUld2U3U4YjVuWk1VbkQ2WldoeG15MVgySXhQVUY3WkFPbC16bE9XMVljWkJxUUVJVy1tcGx1RnRHeDVBSEFXU3ZVRFQzZ0FKSDRFbjFONGtDVktSd2NNNDRhOWttMmx3M2d4ODd1dXNMemxjMjBXREE4ZTdoeVdMRktXWFpiRjlXVzF1LV81eGxhRFlROHU0?oc=5\" target=\"_blank\">Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 21:36:47 GMT"}, {"title": "Novo Nordisk Rises 6% So Far in August: How to Play the Stock - Nasdaq", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOeVFwR3pfSGlyUUEwT2RmZU5TRTExaEQ0bklGOURlcHhIM3A3V2FXNVBTbkJvRXFHRFkxUTVIRXl2Sy01U1A3U3pCT0dneTlGeEpxVGNvZ1dmOXNpNThUMXZsYnk5LVVTOFdsZWk4TXQ3R2dhVzhwc3hTd21SMUtPZWRGalVmQmtR?oc=5\" target=\"_blank\">Novo Nordisk Rises 6% So Far in August: How to Play the Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>", "publishedAt": "Wed, 13 Aug 2025 14:47:00 GMT"}, {"title": "NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar", "description": "<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxNeEtvV0NDZU00NXVYWTNSVmw0R2F5ZzMzMVNxNElVQmdma2FiYVBXUFBfLTZidmg5WWNmNm1JbGh5NFBlWnZCN1kwc3JDX2I1WGxaRHZxYXdWUTdxbGo2S0VEejlySlVXa1VGYXRpeTFXSHdnSlhGdjlhWnM0dkRQVlBCeHJGb1dVUUxHUHJEZkFuNkg5MXBlR2NGMkF3Tk9CVmVwSDh0Z2IzMjVKNDgxSGpaWlJzbDlOMWZfdXcyN1ZjVTFfcndFYUJ3ZFRsOTVFTkV4Smd0LXd4VUF3Y0lMcV9JTVJrR0hGOWg0OHF0OXI2cGtTT0hRb3JSVUhURlNlWGI5aHEyeWhQdDlx?oc=5\" target=\"_blank\">NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Morningstar</font>", "publishedAt": "Thu, 14 Aug 2025 12:45:00 GMT"}, {"title": "Here's Why Novo Nordisk (NVO) is a Strong Growth Stock - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTE1WRGJUcjNmdjFCbGduT3Y1QnI5LUNkTkZuMVlpNnh2a1N2WU85SVBmS0k2ZERUbVpZcnhseC1yQnV2akZWbmg4QlNncUZZeS1mVkRPa1RIRVVkYVFnNk5hTVFRN3J1WEtNY0VGUnhBVWcwVFhaMkJsN1JhcXg?oc=5\" target=\"_blank\">Here's Why Novo Nordisk (NVO) is a Strong Growth Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 13:45:02 GMT"}, {"title": "Novo Nordisk: Watching Value Investors Buy The Dip Hurts My Eyes (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNYUJCZzFQejdoNUtmeHgwYm9Ma192UmRTbUlzX2Jncm9iV1A1N0JrTlE4SEd0VnZzSHJmYjZDTktlUUdTUnJ2RE11ZFRaZC1xRmVFUzlJOW9xd2RxX0thaHZBTjVsUmstbUJFSUlpTDNTdmhYa3lYU1Eta3ZuZUZoVDVQT01iTS1RUGkzb1BNM1VyaldLOGdKM1dwSXpjVDNGc3JpVHlQYw?oc=5\" target=\"_blank\">Novo Nordisk: Watching Value Investors Buy The Dip Hurts My Eyes (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 15:51:36 GMT"}, {"title": "Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPZEVCMFY3OEs3Nk9kZ0Fkd2M3NG9uVHhrLU9wN3JHUnBsRmRDSGhYS0d6UldTZVgtdms1ZzVMMGduNTlWLVcxSnhhRVhTOUJBRzROVjlKNWZ5cmRIV0dhV0hfa2hpTHp2Y25CMFRrWlhGaG9tY0E1RDQ5dVctV3JBOU1PNkt4NV9aajlYR1RmcksyMlZqNHB3eG1Cc1kzVk9KTG1KTnRNWHFHWFdXREx0QUpZTUtrVDJudXRSdTdKMnhHaEVDVmlPWjZYUVRyY2FSRUFmOE9oUQ?oc=5\" target=\"_blank\">Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 21:48:07 GMT"}, {"title": "Why I Tripled My Novo Nordisk Position (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxQYmpRVnZ3Uy1NY1hpTmdUYS1oeGVjT3NORmdqSWczYnNrcXlid25Fb2NhVHZTN0JCSVd5UGFsV0JXZ0t5dWtiNzF6bTNtZEFUdGlPZEhzV2dLdG9odHZSdi1EeUJvV2lPRWQ0amFSenFWaUVZQS1oMnQxLWhheEJiaGp5ZGRDUQ?oc=5\" target=\"_blank\">Why I Tripled My Novo Nordisk Position (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Sun, 10 Aug 2025 12:29:14 GMT"}, {"title": "Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxONDRjZy1COHhyUXZBYmJaVVI1OXY3T1hjZWNsMkpKOUVMZVFFVlRLZEdIQXZkUVBYSE5ZcjdranM0OUJJenNEYjRyMzhTNzZOMnJ2d1BmQUk2VVJ1amRUSHpud1NyYmVBY1RHb1p2X1JUYVhRdFR6WjhlU3RaUlhNUFNid21RbFRqNFE?oc=5\" target=\"_blank\">Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 13:00:03 GMT"}, {"title": "A Cure For Novo Nordisk (NYSE:NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiakFVX3lxTFBGaXFacXFNYWZCbFNUTWNtRnpXaW44dnlLaVFYOFpESW9aUVBKc1M4UXdYVXRtZE9vSEI1QWdXbGd4TXJSOTd3SzRsaXJUVEdNOGw5Ny1qeVU0dTBGcF8wczVqOTVpQkgzQ3c?oc=5\" target=\"_blank\">A Cure For Novo Nordisk (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Wed, 13 Aug 2025 17:34:41 GMT"}, {"title": "Novo Nordisk Reduces Sales And Operating Profit Outlook For 2025 - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNVnI5ZGV5dnFzREEtWklnVFVVLU1iT2hna2xVX3Z2RG53Ti1mcUJTTkJlVzQtUGt1MXVsZjRjbTJLTEY3UVJIR0FXTjNrOExBU0Z4QkRXUHRmNk1RaERZNWo5WkNFYy1mYkdDRWlFeFlnUHFSTHBfMVI3N2gyY0I1NE41bXlDT3FkSnc?oc=5\" target=\"_blank\">Novo Nordisk Reduces Sales And Operating Profit Outlook For 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 00:23:42 GMT"}, {"title": "Novo Nordisk: The Falling Knife That Keeps Giving - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOV2Y1SzhmT2NWVHp5bmJ1TE5uaXVCRnNuLXh2Rl9zdlMwTzRxajJoX0xfWkJLNFQzYzEteGdvcjFiZkVoM3E5cVY5YzlVTF9pUUxZUk8tSlNLb2FnWlF0ZmhBdzJvWG54OHlOT2IzclNSN2JhYllrLWl6ei1HcWdEX0x4VHdHOWNTUWdlQTZn?oc=5\" target=\"_blank\">Novo Nordisk: The Falling Knife That Keeps Giving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Wed, 13 Aug 2025 15:14:29 GMT"}, {"title": "Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - uk.finance.yahoo.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNeEQ1a1JoNXBjU0tfc2VKSmcyTEoxVURfcFVScWRTUWFyWGpsSjVUOU5iVThLZnd5ZF9YMGVBQy13cHNrQ09BanlfbW9heS1SdC12SGN1dkhFV3JYZzVXb0FSNldfREptbnJSdEtxazN0SGc3Tk00R2Y2bjhiQ0xYTFlGNkVZN09vZnc?oc=5\" target=\"_blank\">Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">uk.finance.yahoo.com</font>", "publishedAt": "Tue, 12 Aug 2025 12:26:00 GMT"}, {"title": "The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxQX3NFcDFLZzVaRjlpal9MQXczYmNwN1k0RGpkSjFHVkNuaEJSd2czc0JlaENuejBET2NsUFVxRmRqclhlNmZlV0tKcGl2U0FTZGR3dktESE1HWWhJbXRJTTN0aWR4azAxOXFvaWxHbnBhZ2hmeWhVci1zcEwxc0lndWNDTFYxNVphS2loNw?oc=5\" target=\"_blank\">The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Thu, 14 Aug 2025 13:28:00 GMT"}, {"title": "Industry Analysis: Pharmaceuticals Like Novo Nordisk Offer Long-Term Opportunities (NVO) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPdDNiS0xDTEFtYzNHN2QwelJBaDUwY2RmZURTamJGOTlWWGFZT1BGaTU2dWJ3Z0JGQXRnWHlxMzJXYmRWTmFBTkVTUnBTUkFsMVJYbVhDZ1lObTdmZFZzMi1vejlmM3gwcEpCSzNIbWVDVkZFVVNBdGU4MnllT2gxRXJHTW9YejlKZHdBeUYycm9EUzRyelpWQk5TZ3h4SzVuMl9iOGgzX3lYSTZjZlUwVmJZS2lIa0Q5?oc=5\" target=\"_blank\">Industry Analysis: Pharmaceuticals Like Novo Nordisk Offer Long-Term Opportunities (NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 14:18:03 GMT"}, {"title": "HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTFBOSnhMeW1ZSUtoOWtJdkFISEFwNnhwcEdDQjA4blBpc1pROGFtcHVFS0Y5SUVyWUFkaFBNdmpETXU3ZmY3NkFWMkRvaDVHc3c2NUhYOV9PWkRKZEFoUGp5MFNjeWxlSEd0V29JUnJrOUZ0MmFPYnJoWVNFUS1VekE?oc=5\" target=\"_blank\">HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Wed, 13 Aug 2025 19:32:32 GMT"}, {"title": "Novo Nordisk A/S: Wegovy\u00ae approved in the US for the treatment of MASH - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQbVpOeGpjMVdRdVZEaDVJNTJDR1hWeFYwYWxNYXhwMnNDdFI5QzdPVFVhSzBCZXVyZ2R1RGhUTHR2YlVoVFJjZi1pV3dtNXpnWjRDM2gyMnUyVFpjTG00NkdwR3N5dzhRVGpHSXR5QmUxbE9kcmFxOElzaGdUVEU1VGdoaw?oc=5\" target=\"_blank\">Novo Nordisk A/S: Wegovy\u00ae approved in the US for the treatment of MASH</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Fri, 15 Aug 2025 21:23:00 GMT"}, {"title": "Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObldUU2FETTF1cmtSWVBoZGV3U3lWNmdmdEdrcmJ0NXFYUWZLSWFQN0Q3ckNGQ1JKVEFvZVlfVmltcVRBWnh5TDJBZFI1Vm5wQ0tacXVWZUE0aVY0SFRFcGNUSlJOd3VLUEZsUnQ5amo3VC1qTzh3Zk9tOXZwcnh5TnFNcTQ3dw?oc=5\" target=\"_blank\">Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Wed, 13 Aug 2025 20:30:00 GMT"}, {"title": "Investors in Novo Nordisk A/S Should Contact Levi & - GlobeNewswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMikAJBVV95cUxOalRFMkdvc0JadVNRWFNvVERHdDMwRm53U3Z6VmRTVzItNF94RjVuSUhtcTdTUTFNMWdZaFk1dDlEWE8xOXhFRnZ1czdLemdBc1pRejdlOEhOYlBGVFctQWlsaElYYnlrVjF3cWpQSGZIOUk0S3JFQ0xfSEJMNEtjUW1CYTNUNXZJRnM4d25uY2FzSm5VaHJKTEg5ano5X25KY2xJNVBjYWdkd1FvTzFUNk5IVWVJRTBfYVEwV2FLNHIyVEw0UjRZX2dpazZuOGxhdUNvZlRiaXdmSnlkN1otT3V0YnBuSDlzRU9fajhDYWxfbURoQmY0X3JJNGhwRlJ1bGlUY19lQXhwdHZoZFV6Yg?oc=5\" target=\"_blank\">Investors in Novo Nordisk A/S Should Contact Levi &</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GlobeNewswire</font>", "publishedAt": "Thu, 14 Aug 2025 20:42:26 GMT"}, {"title": "NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgJBVV95cUxOVkVHSC1HTC10cWhtZUEwOFg0Vk9Pa01GUTFMOEt5YUNRbGdwblA3UUhBZDhBMUVxSldaQ2E0cmJUSFJhQ1g2WjJWY1VuTEVrN0lHMG5BSi1BYVAzeExwanMtQVoyaEFJTXJDZE5fUkdNZkV0blZCYWtTai1MWHUtVlgtNzAwNXh0aU5yOGx3NFVoSnQ3NEhlVS1SZkNETzlHOUJCT0tzU3NHMnFiS19rTnZLQ0h1NWFlTHdiUTFxVlFsT09DajR0TzlhRDh4LWpKcDdQbHVFOUwwWmNnbmlnZGljUzhlRDBNRFYweWxCQUJuaDJLcU5ObVpWbk9nc1NQbDBoalRn?oc=5\" target=\"_blank\">NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>", "publishedAt": "Thu, 14 Aug 2025 12:45:00 GMT"}, {"title": "Deadline Alert: Novo Nordisk A/S (NVO) Investors Who Lost - GlobeNewswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMitAJBVV95cUxNalpGSnVfc3p1elU1Q0twV2k3dVo5VGQ2bF9oUXN5T3FZVE1QU3RYR0hlcnpHZndrM0RSYTNVNHRJbGd3MlZRUUdxRlI5c04yZXliUDgxRWFTSHVrZHEtcnBTWkRybXdNSDVKTGVWZW1DUHJ5NVJnak94eXhwVHp3aXA5OGpKS2FtYXB2UTNDT1dacUQ5WTUzUF9PRlJpODAyUWUtVDFPMVkzLXBMX3BCOVRjUzFHQU1FbTkzb1EzS3F3eXlWYnlWQkhCemgwZVlpRWFUaFl3V09HYzB2LWxwY3I3NFM4RC1DQ2NKd3g4ejlSWWE0UTVCRkNFQ1BLZWVzckhuMDFPb3JpR2hZb2RMbVFzUk5uRjdyc1c4aURvSUt2SVNPbm9BWEJfVWEyazJRS2Q2Qw?oc=5\" target=\"_blank\">Deadline Alert: Novo Nordisk A/S (NVO) Investors Who Lost</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GlobeNewswire</font>", "publishedAt": "Tue, 12 Aug 2025 16:01:20 GMT"}, {"title": "Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly - MarketBeat", "description": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNaFEyUmxKMTh3blRmdHprdWhyd2N3YVFPV01SNTNELW02WkgyRU1YNkZjNTM1WDBBNjRaVV9ZTV9OcFI3WTBVMDdkMlZPQklyMXVDeTI3V0E1R3YzSG1YY1ZhYWhDQzJNY1hiU0U0eF9xejYzczlnZFVENHF4WC1ZQlVHZmoxLWZQMWpwcjVGWjE5OHJ6Q3hNZ1k4bE5qXzJFQUhLNTJmSQ?oc=5\" target=\"_blank\">Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>", "publishedAt": "Sat, 09 Aug 2025 14:01:12 GMT"}, {"title": "Novo Nordisk\u2019s Wegovy Gets US Approval for Liver Disease - Bloomberg.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTEFVS3ZYV0VOX3VXaTg5X1ZZQkttSGMzWWt5UTVUWnpvLTgxellZM1BmUEZGQ1JwY1Z0aElwRlBKVm1ucUhvQlBFQUZ0Q0U4QUMtX1NBMWdSTkVuMUV2b3lqdGRYVDV3M1RVaU9zSkw3blctWVpzRU1KcTd5cE9tOXJwUzFqUUFMZzN2azUzTEExRC14blkwRzVOUVdGSWJoSndEcXdVc0xOdnM?oc=5\" target=\"_blank\">Novo Nordisk\u2019s Wegovy Gets US Approval for Liver Disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg.com</font>", "publishedAt": "Fri, 15 Aug 2025 21:48:21 GMT"}, {"title": "NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit - PR Newswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQcmh3SU9RS2wybm1oQ0FBc3pKeXZmR2p2bzRFOUdPMFJVMnVpTW81M0Ffcm8wYnRLd280SHRKb2RRNXN4cExOeXBUNWRIRjFpNHNRWld1dzNQODJNenBLNlZGdUl0cU11SzB5b1N3NWFQSDkxZU1GVVpsNFlXRGFHWi14dHFSRGZldVQ5OUg1S0pDZnhpWm5mX1JyVk1pZ3JTdGM3VTJkRnRLOHpoSDl6YVJzbUQxX0Vxai1GamJmajZveGhYcklvZkxUMVViTmw2?oc=5\" target=\"_blank\">NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>", "publishedAt": "Fri, 15 Aug 2025 20:45:00 GMT"}, {"title": "Why Is Hims & Hers Stock Falling Tuesday? - Hims & Hers Health (NYSE:HIMS), Novo Nordisk (NYSE:NVO) - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxOUnBhYzQwWU9vZU8wMkxDWlFWczlYOGR4UUtGc3RrNEVBdDFacTZkRnJvR29IU19lYXhSSEg4Q01ESVJvdk9yZTBVMkUzbzQ0M2QzbTUyeHhPWThtQlBLVWRpbmgyaWVEcUtMbFdzX2liWTJHU2xLcFFWb3FoOVVBeG1oQzV3MlNyNUVPNmF0dmpHSWFzMGFzdjBkVUpQNXBkbXREbDNhZlhoOTFUSnpFYUh4aXhxa3I2Q1U0dlR1V0daM2FaZkxB?oc=5\" target=\"_blank\">Why Is Hims & Hers Stock Falling Tuesday? - Hims & Hers Health (NYSE:HIMS), Novo Nordisk (NYSE:NVO)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Tue, 12 Aug 2025 16:32:37 GMT"}]